MICROENCAPSULATION OF BIOACTIVE SUBSTANCES AND METHODS OF MAKING THE SAME

(19)

(11)

EP 2 410 879 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	14.08.2019 Bulletin 2019/33

(45)	Mention of the grant of the patent:
	08.05.2019 Bulletin 2019/19

(21)	Application number: 10756764.6

(22)	Date of filing: 24.03.2010

(51)

International Patent Classification (IPC):

A23P 10/35^(2016.01)
A21D 2/14^(2006.01)
A23L 5/44^(2016.01)
A23L 33/12^(2016.01)
A23L 33/175^(2016.01)

A23L 29/10^(2016.01)
A23L 29/00^(2016.01)
A23L 33/15^(2016.01)
A23L 33/16^(2016.01)

(86)	International application number:
	PCT/US2010/028432

(87)	International publication number:
	WO 2010/111347 (30.09.2010 Gazette 2010/39)

(54)	MICROENCAPSULATION OF BIOACTIVE SUBSTANCES AND METHODS OF MAKING THE SAME MIKROVERKAPSELUNG VON BIOAKTIVEN STOFFEN UND HERSTELLUNGSVERFAHREN DAFÜR MICROENCAPSULATION DE SUBSTANCES BIOACTIVES ET PROCÉDÉS DE FABRICATION DE CELLES-CI

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30)

Priority:

26.03.2009 US 163728 P

(43)	Date of publication of application:
	01.02.2012 Bulletin 2012/05

(73)	Proprietor: Advanced BioNutrition Corp.
	Columbia, MD 21046-2545 (US)

(72)	Inventor:
	HAREL, Moti Pikesville MD 21208 (US)

(74)	Representative: ABG Intellectual Property, S.L.
	Avenida de Burgos, 16D Edificio Euromor 28036 Madrid 28036 Madrid (ES)

(56)

References cited: :

EP-A1- 1 649 763
KR-B1- 100 708 810
US-A- 5 789 014
US-A1- 2005 019 416
US-A1- 2007 042 184

WO-A2-2008/017962
US-A- 4 765 996
US-A- 5 897 896
US-A1- 2006 051 425

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).